SNYRQ
What one share of Synergy CHC holds
Medicinal Chemicals and Botanical Products
Our current brand portfolio consists of two marquee brands, FOCUSfactor, a clinically-tested brain
Synergy CHC’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-03-31; the balance sheet is as of 2026-03-31.
| Sales | $2.66 |
|---|---|
| Profit | −$1.52 |
| Cash and investments | $0.03 |
| Debt | $2.45 |
| Book value | −$2.25 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2013 | — | −$0.00 | — | −$0.00 | — | — |
| 2014 | — | −$0.01 | — | −$0.01 | — | −$0.00 |
| 2015 | $0.20 | −$0.11 | $0.00 | −$0.01 | — | $0.07 |
| 2016 | $0.43 | −$0.01 | $0.00 | $0.07 | — | $0.08 |
| 2017 | $0.40 | $0.01 | $0.00 | −$0.01 | — | $0.10 |
| 2018 | $0.38 | −$0.07 | $0.00 | $0.01 | — | $0.04 |
| 2019 | $0.33 | −$0.10 | — | $0.03 | — | −$0.06 |
| 2023 | $5.80 | $0.86 | — | $0.06 | — | −$3.70 |
| 2024 | $4.57 | $0.28 | — | −$0.63 | — | −$1.95 |
| 2025 | $3.12 | −$1.27 | — | −$0.27 | — | −$2.05 |